Prevalence and specificity of myelodysplastic syndrome with jak2 mutation in Morocco
Background: The JAK2 V617F mutation has been noted in a majority of cases of polycythemia Vera, essential thrombocythemia, and primary myelofibrosis patients but occurs less frequently in myelodysplastic syndrome (MDS) about 5% of the cases; In Morocco, the Incidence of MDS will increase significantly in our country, MDS will be the disease of national public health. The aim of the current study was to determine prevalence of JAK2V617F mutation in Moroccan patients with MDS, and to compare characteristics of JAK2 mutation group to JAK2 wild type group.